Cite
HARVARD Citation
Kirschey, S. et al. (n.d.). Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B‐cell lymphoma: mature results of a phase II multicentre study. British journal of haematology. pp. 824-834. [Online].